| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B Blocks Bone Erosion Associated with Inflammatory Arthritis1
Departments of
*
Orthopaedic Research Laboratory,
Medicine,
Pathology, and
Cell Biology and Physiology, Barnes-Jewish Hospital at Washington University School of Medicine, St. Louis, MO 63110
Inflammatory arthritis is associated with devastating joint tissue destruction and periarticular bone erosion. Although secreted products of infiltrating immune cells perpetuate the inflammatory response, the osteolytic component of this disease is a direct result of localized recruitment and activation of osteoclasts. Given that NF-
B plays a central role in both processes, the function of this transcription factor was examined. Using a mouse model of autoreactive Ig transfer that engenders inflammatory arthritis, we show numerous osteoclasts in the articular joint tissue associated with progressive periarticular osteolytic lesions. Moreover, cells retrieved from these joints exhibit heightened NF-B activity. Importantly, direct administration of dominant negative*I-B or tyrosine 42-mutated I-B (Y42F*I-B) proteins into mice before induction of the disease attenuates in vivo activation of the transcription factor. More importantly, these I-B mutant forms significantly inhibit in vivo production of TNF and receptor activator of NF-B ligand, and block joint swelling, osteoclast recruitment, and osteolysis. Thus, NF-B appears to be the centerpiece of inflammatory-osteolytic arthritis and direct inhibition of this transcription factor by unique and novel I-B mutant proteins blocks manifestation of the disease.
This article has been cited by other articles:
|
|
 |
|
  B. Sung, A. Murakami, B. O. Oyajobi, and B. B. Aggarwal Zerumbone Abolishes RANKL-Induced NF-{kappa}B Activation, Inhibits Osteoclastogenesis, and Suppresses Human Breast Cancer-Induced Bone Loss in Athymic Nude Mice Cancer Res., February 15, 2009; 69(4): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gilchrist, W. R. Henderson Jr., A. E. Clark, R. M. Simmons, X. Ye, K. D. Smith, and A. Aderem Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation J. Exp. Med., September 29, 2008; 205(10): 2349 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Madhavan, M. Anghelina, D. Sjostrom, A. Dossumbekova, D. C. Guttridge, and S. Agarwal Biomechanical Signals Suppress TAK1 Activation to Inhibit NF-{kappa}B Transcriptional Activation in Fibrochondrocytes J. Immunol., November 1, 2007; 179(9): 6246 - 6254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Teitelbaum Osteoclasts: What Do They Do and How Do They Do It? Am. J. Pathol., February 1, 2007; 170(2): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Stuhlmeier The Anti-rheumatic Gold Salt Aurothiomalate Suppresses Interleukin-1beta-induced Hyaluronan Accumulation by Blocking HAS1 Transcription and by Acting as a COX-2 Transcriptional Repressor J. Biol. Chem., January 26, 2007; 282(4): 2250 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Korcok, L. N. Raimundo, X. Du, S. M. Sims, and S. J. Dixon P2Y6 Nucleotide Receptors Activate NF-{kappa}B and Increase Survival of Osteoclasts J. Biol. Chem., April 29, 2005; 280(17): 16909 - 16915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dai, T. Hirayama, S. Abbas, and Y. Abu-Amer The I{kappa}B Kinase (IKK) Inhibitor, NEMO-binding Domain Peptide, Blocks Osteoclastogenesis and Bone Erosion in Inflammatory Arthritis J. Biol. Chem., September 3, 2004; 279(36): 37219 - 37222. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
